Voltron Therapeutics, a Laidlaw Venture Partner, Announces Selection of Therapeutic Targets for Immuno-Oncology Program

The Vaccine and Immunotherapy Center in partnership with Voltron Therapeutics, Inc. has selected three initial cancer targets and pre-clinical protocols for its VaxCelerate self-assembling vaccine (SAV) platform, in the immuno-oncology (IO) setting and are aiming to file an IND for at least one cancer indication in mid-2022.

Please read the press release below for more detail on this exciting progress.

View Newswires Article

B cells do more than just help fight infection: a new study shows that they can support tissue repair and regeneration after injury

An exciting recent publication in the FASEB Journal by VIC researcher’s Ruxandra Sîrbulescu, PhD and Mark Poznansky, MD, PhD on ‘B cells do more than just help fight infection: a new study shows that they can support tissue repair and regeneration after injury’

Please read the press release below or click on the link to read the full paper.

View MGH Press Release
View FASEB Journal Publication